Teva-Dasatinib 50 mg (Dasatinib (Dasatinib Monohydrate) TABLET) 50 MG

TEVA-Dasatinib 50 MG tablets are a pharmaceutical product used to manage certain medical conditions. This oral medication is manufactured by Teva Canada Limited and is available in a pack size of 60 tablets.

Strength

50 MG

Pack Size

Manufacturer / TM Owner

TEVA CANADA LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Dasatinib, the active ingredient in TEVA-Dasatinib, is commonly used in the treatment of specific types of cancer. It works by targeting certain proteins in the body to help control the growth and spread of cancer cells. Patients often wonder, 'What is dasatinib used for?' and the answer typically involves its role in managing chronic myeloid leukemia and acute lymphoblastic leukemia.

Side Effects

Common effects of dasatinib may include nausea, diarrhea, and fatigue. Some users might experience skin rashes or swelling. It's important to note that individual responses to the medication can vary, and not everyone will experience these effects.

Precautions & Warnings

TEVA-Dasatinib should be handled with care and stored as directed. It is essential to follow the advice of a healthcare provider regarding its use. Pregnant women or those planning to become pregnant should discuss the use of dasatinib with their healthcare provider.

Avoid Interactions

Dasatinib may interact with certain medications, including those that affect liver enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare provider.

Frequently Asked Questions

TEVA-Dasatinib 50 MG is used to manage certain types of cancer, including chronic myeloid leukemia and acute lymphoblastic leukemia.

TEVA-Dasatinib is an oral medication that should be taken as directed by a healthcare provider.

Common side effects of dasatinib may include nausea, diarrhea, fatigue, skin rashes, and swelling.

Dasatinib may interact with certain medications, so it is important to consult a healthcare provider before combining it with other drugs.

Pregnant women or those planning to become pregnant should discuss the use of dasatinib with their healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.